Mezzion Pharma Co. Ltd
Clinical trials sponsored by Mezzion Pharma Co. Ltd, explained in plain language.
-
Heart drug shows promise for teens with rare heart defect
Disease control CompletedThis study looked at the long-term safety of a drug called udenafil in teenagers who have a rare heart condition where one side of the heart is not fully formed. The teens had already had a special surgery called the Fontan procedure. The study lasted 12 months and included 301 p…
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Heart drug may ease liver strain in kids with rare condition
Disease control CompletedThis study looked at whether a heart medication called udenafil could reduce liver stiffness in 88 children with single ventricle heart disease. Liver stiffness is a sign of liver damage that can happen in these children. The study measured liver stiffness using ultrasound and MR…
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated May 01, 2026 15:59 UTC